PTJ
DMTK

Paul Tudor Jones’s DermTech, Inc. Common Stock DMTK Stock Holding History

Paul Tudor Jones’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,200
Closed -$569K – 2027
2021
Q1 		$569K Buy
+11,200
New +$586K 0.01% 1093

Other funds holding DMTK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Paul Tudor Jones's DMTK Position: Q2 2021 in Review

Paul Tudor Jones sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 11,200 shares — an estimated $569K sold.

Paul Tudor Jones first reported a position in DMTK in Q1 2021 and held it in 1 quarter. The position peaked at $569K in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Paul Tudor Jones reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 11,200 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $569K.
  • Paul Tudor Jones first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Paul Tudor Jones's DermTech, Inc. Common Stock position peaked at $569K in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Tudor Investment Corp's 13F filing for Q2 2021, filed 16 Aug 2021.